[PDF][PDF] Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen

Groupe d'Etude et de Traitement du Carcinome … - …, 2004 - Wiley Online Library
The growth of hepatocellular carcinoma (HCC) is thought to be dependent on androgens, as
androgen receptors are present in most of these tumors. The aim of this multicenter trial was …

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric …

C Grimaldi, H Bleiberg, F Gay, M Messner… - Journal of clinical …, 1998 - ascopubs.org
PURPOSE The aim of the study was to evaluate the efficacy of antiandrogen therapy on
overall survival and response in unresectable hepatocellular carcinoma (HCC). PATIENTS …

Sex hormone receptors in hepatocellular carcinoma: is there a rationale for hormonal treatment?

L Boix, J Bruix, A Castells, J Fuster, C Bru, J Visa… - Journal of …, 1993 - Elsevier
The present study assessed the tumor concentration of receptors for estrogens,
progesterone and androgens in a series of Western patients with hepatocellular carcinoma …

Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial

EK Manesis, G Giannoulis, P Zoumboulis, I Vafiadou… - Hepatology, 1995 - Elsevier
We tested the hypothesis that a combination of sex hormone suppression and inhibition of
their target receptors might improve survival for patients with hepatocellular carcinoma …

Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosterone

A Forbes, ML Wilkinson, MJ Iqbal, PJ Johnson… - European Journal of …, 1987 - Elsevier
The male preponderance in cirrhotic patients with primary hepatocellular carcinoma (HCC)
and the presence of androgen receptors in tumour tissue suggest possible benefit from anti …

Hormonal treatment of human hepatocellular carcinoma

M Di Maio, E De Maio, A Morabito… - Annals of the New …, 2006 - Wiley Online Library
Animal models of experimental liver carcinogenesis and epidemiological studies in humans
suggest a relationship between sex hormones and hepatocellular carcinoma (HCC). In …

Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients

A Castells, J Bruix, C Brú, C Ayuso, M Roca, L Boix… - Gastroenterology, 1995 - Elsevier
Background & Aims: The progression of hepatocellular carcinoma may be influenced by
estrogens. This has offered the rationale for evaluating the therapeutic usefulness of …

Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?

S Pignata, B Daniele, C Gallo, R De Vivo… - European Journal of …, 1998 - Elsevier
In the past 20 years, a number of studies have investigated the relationship between sex
hormones and liver cancer. Experimental studies indicate that a dynamic process, with …

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma

F Farinati, N De Maria, A Fornasiero… - Digestive Diseases and …, 1992 - Springer
Clinical and experimental evidence indicates that estrogens are involved in the control of
hepatocyte proliferation both in normal and in neoplastic conditions. Thirty-two cirrhotic …

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen

F Farinati, M Salvagnini, N De Maria, A Fornasiero… - Journal of …, 1990 - Elsevier
The liver is an estrogen responsive organ. Clinically, estrogens may play a role in the
induction of liver tumors and, experimentally, estrogens are involved in the control of …